JPMorgan's Kolanovic says buy more stocks on vaccine news, market will look past latest Covid surge

People walk past the New York Stock Exchange in the Manhattan borough of New York, November 10, 2020.
Carlo Allegri | Reuters

(This story is for CNBC Pro subscribers only).

JPMorgan's top-rated equity strategist Marko Kolanovic said Friday that the positive news about Pfizer's vaccine candidate was a "game-changer" that could help the market jump more than 10% in the next few months.

Kolanovic, the bank's head of macro quantitative and derivatives strategy, said in a note that the expected vaccine should spur investors to look through the rising Covid-19 cases this winter and focus on the economic recovery ahead.

More In Pro Insight

CNBC ProThe surprising moves in bond yields could be an important guide for stocks
CNBC ProRobinhood has become part of the meme stock craze it helped create. What investors should know
CNBC ProThese stocks are the right plays for the next stage of the economy, Wolfe Research says